Fatma Tatar

Fatma Tatar, MD, currently serves as the Medical Affairs Lead at AstraZeneca since July 2022. Previously, Fatma worked as a Senior Medical Manager at Pfizer from July 2021 to May 2022, overseeing the Lung Franchise and Biosimilars Portfolio, and served as a Medical Manager focusing on oncology, particularly on NSCLC targeted therapies and project management, including a non-interventional study of Crizotinib presented at the World Lung Cancer Congress and the European Society of Medical Oncologists Congress in 2018. Fatma's experience also includes a role as a Medical Science Liaison at Roche, where the focus was on oncology treatments, and at AstraZeneca Türkiye, concentrating on diabetes and metabolism drug launches.